Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Senti Biosciences Q1 EPS $(0.26) Up From $(0.42) YoY

Author: Benzinga Newsdesk | May 09, 2024 05:17pm
Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.26) per share. This is a 38.1 percent increase over losses of $(0.42) per share from the same period last year.

Posted In: SNTI